Cover Image
Market Research Report
Product code 
1018113

North America Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ; Functionality ; Type of Formulation

Published: | The Insight Partners | 155 Pages | Delivery time: 1-2 business days

Price

Back to Top
North America Pharmaceutical Excipients Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product ; Functionality ; Type of Formulation
Published: June 4, 2021
The Insight Partners
Content info: 155 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The pharmaceutical excipients market in North America is expected to grow from US$ 1,865.4 million in 2019 to US$ 2,877.1 million by 2027; it is estimated to grow at a CAGR of 5.6% 2019-2027. Multifunctional excipient refers to excipients playing several roles in a dosage type or a drug delivery method. Several APIs (Active Pharmaceutical Ingredients) demonstrate low dissolution rates and poor solubility in aqueous condition. Oral bioavailability of these compounds is low due to poor solubility. In order to increase the bioavailability of these poorly soluble products, formulation methods are used to improve their aqueous solubility and dissolution. ~90% of newly discovered therapeutic compounds in the developmental process are reported to exhibit low aqueous solubility. Additionally, ~40% of new medicines prescribed to patients in hospitals are estimated to have relatively poor aqueous solubility. These drugs require functional excipients to help resolve their weak physico-chemical properties. Multi-functional excipients are used to generate dosage forms that can minimize the number of doses by adjusting the rate of drug release or enhancing drug delivery by targeting the gastrointestinal tract where drug absorption is maximum. In addition, functional excipients are used to re-formulate existing drugs to create efficient and cost-effective products. As the production of novel drug delivery systems is progressing, sophisticated excipients are required to impart these properties to the final product. Moreover, increasing prevalence of chronic diseases and a growing propensity to consume oral formulations are some of the factors anticipated to fuel demand for multi-functional excipients in the pharmaceutical industry. Multifunctional excipients play an important role in the development of intelligent drug delivery systems, thereby leading to the improvement of the achieved therapeutic effect. Therefore, the growth of the pharmaceutical market backed by multi-functionality excipients is driving the market's growth.

The market for pharmaceutical excipients market is segmented into product, functionality, and type of formulation. Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals, and other products. In 2019, the organic chemicals segment accounted for the largest share, moreover the same segment is expected to grow at a fastest CAGR during the forecast period. Organic chemicals are chemical compounds that contain carbon-hydrogen bonds, and these can be found in natural or synthetic form. Most organic chemicals are carbon based, hence produced by plants or animals, whereas synthetic organic chemicals are produced through chemical reactions. Organically derived pharmaceuticals excipients include oleochemicals, carbohydrates, petrochemicals, proteins, povidones, acrylic polymers, mineral hydrocarbons, starch, cellulose, and others. The most used oleo chemical-based pharmaceutical excipients are fatty alcohols, mineral stearates, glycerin, and lipids. The organic segment is expected to lead the market owing to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry.

The global supply chain of medicines is under pressure because of a deficit of raw materials such as active pharmaceutical ingredients (APIs) and excipients. A large share of the medicines sold in the United States is produced in China and India, while almost 80% of the US API demand is met by these two countries. As one of the world's largest producers of generic medicines (producing 20% of global generics supply), India imports almost 70% of its APIs from China; therefore, disruption in its supply chain has resulted in drug supply shortages. In the likely and best-case scenarios, the effects of disruptions on pharmaceutical production and consequently on excipients demand caused by lockdowns and travel and transport bans across various countries especially in the US is relatively short term. According to the research study, around 24% of patients with COVID-19 suffered from acute heart failure (AHF) in the US when they were first identified with the COVID-19. However, this does not mean that all 24% of COVID-19 patients will suffer from acute heart failure in the future. The demand for drugs is increasing with the rising number of patients with cardiovascular diseases during this pandemic. There is rise in the discovery of clinical drugs for COVID-19 due to which pharmaceutical excipients market is likely to grow. However, the supply disruptions due to extended lockdowns in various countries can have a more substantial impact on oral solid dosage drug manufacturing and, in turn, significantly impact the demand growth of excipients in the North American region.

The overall North America pharmaceutical excipients market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the North America pharmaceutical excipients market with respects to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants who typically take part in such a process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers along with external consultants such as valuation experts, research analysts, and key opinion leaders specializing in the North America pharmaceutical excipients market. DuPont de Nemours, Inc.; Roquette Freres; Ashland Global Holdings, Inc.; BASF SE; Evonik Industries AG; Associated British Foods Plc; Archer Daniels Midland Company; Lubrizol Corporation; and Croda International Plc are among a few players operating in the North America pharmaceutical excipients market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America pharmaceutical excipients market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America pharmaceutical excipients market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the pharmaceutical excipients market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution 
Product Code: TIPRE00022815

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Pharmaceutical Excipients Market - By Product
    • 1.3.2 Pharmaceutical Excipients Market - By Functionality
    • 1.3.3 Pharmaceutical Excipients Market - By Type of Formulation
    • 1.3.4 North America Pharmaceutical Excipients Market - By Country

2. North America Pharmaceutical Excipients Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Pharmaceutical Excipients Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Pharmaceutical Excipients Market- North America PEST Analysis
  • 4.3 Expert Opinion

5. North America Pharmaceutical Excipients Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Surge In Generics Market
    • 5.1.2 Growth of the Pharmaceutical Market Backed By Multi-Functional Excipients
  • 5.2 Market Restraints
    • 5.2.1 Cost and Time Intensive Drug Development Process
  • 5.3 Future Trends
    • 5.3.1 Rising Demand and Emphasis on Co-Processed Excipients
    • 5.3.2 Improving Excipient Capabilities due to Nanotechnology
  • 5.4 Impact Analysis

6. Pharmaceutical Excipients Market - North America Analysis

  • 6.1 North America Pharmaceutical Excipients Market Revenue Forecasts and Analysis

7. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Product

  • 7.1 Overview
  • 7.2 Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Organic Chemicals
    • 7.3.1 Overview
    • 7.3.2 Organic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Inorganic Chemicals
    • 7.4.1 Overview
    • 7.4.2 Inorganic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Other Products
    • 7.5.1 Overview
    • 7.5.2 Other Products: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

8. North America Pharmaceutical Excipients Market Analysis and Forecasts To 2027 - By Functionality

  • 8.1 Overview
  • 8.2 Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)
  • 8.3 Fillers And Diluents
    • 8.3.1 Overview
    • 8.3.2 Fillers and Diluents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.4 Suspending And Viscosity Agents
    • 8.4.1 Overview
    • 8.4.2 Suspending and Viscosity Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Coating Agents
    • 8.5.1 Overview
    • 8.5.2 Coating Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.6 Binders
    • 8.6.1 Overview
    • 8.6.2 Binders: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.7 Preservatives
    • 8.7.1 Overview
    • 8.7.2 Preservatives: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.8 Emulsifying Agents
    • 8.8.1 Overview
    • 8.8.2 Emulsifying Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 8.9 Other Functionalities
    • 8.9.1 Overview
    • 8.9.2 Other Functionalities: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

9. North America Pharmaceutical Excipients Market Analysis and Forecasts to 2027- By Type of Formulation

  • 9.1 Overview
  • 9.2 Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)
  • 9.3 Oral Formulations
    • 9.3.1 Overview
    • 9.3.2 Oral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.4 Topical Formulations
    • 9.4.1 Overview
    • 9.4.2 Topical Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.5 Parenteral Formulations
    • 9.5.1 Overview
    • 9.5.2 Parenteral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • 9.6 Other Formulations
    • 9.6.1 Overview
    • 9.6.2 Other Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)

10. Pharmaceutical Excipients Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 10.1 North America: Pharmaceutical Excipients Market
    • 10.1.1 Overview
    • 10.1.2 North America: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)
    • 10.1.3 US: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.1 US: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.3.2 US: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.3.3 US: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.3.4 US: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD Million)
    • 10.1.4 Canada: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.4.1 Canada: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.4.2 Canada: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.4.3 Canada: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.4.4 Canada: Pharmaceutical Excipients market, by Type of Formulation, 2018-2027 (USD million)
    • 10.1.5 Mexico: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.5.1 Mexico: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
      • 10.1.5.2 Mexico: Pharmaceutical Excipients Market, by Product, 2018-2027 (USD Million)
      • 10.1.5.3 Mexico: Pharmaceutical Excipients Market, by Functionality, 2018-2027 (USD Million)
      • 10.1.5.4 Mexico: Pharmaceutical Excipients Market, by Type of Formulation, 2018-2027 (USD million)

11. Impact Of COVID-19 Pandemic on North America Pharmaceutical Excipients Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. COMPANY PROFILES

  • 13.1 DuPont de Nemours, Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Roquette Freres
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Ashland Global Holdings Inc.
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 BASF SE
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Evonik
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Associated British Foods plc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Archer Daniels Midland Company
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Lubrizol Corporation
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Croda International plc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. US Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. US Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Canada Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico Pharmaceutical Excipients Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico Pharmaceutical Excipients Market, by Functionality - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Mexico Pharmaceutical Excipients Market, by Type of Formulation - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Organic Developments Done By Companies
  • Table 11. Inorganic Developments Done By Companies
  • Table 12. Glossary of Terms, Pharmaceutical Excipients Market

List Of Figures

  • Figure 1. Pharmaceutical Excipients Market Segmentation
  • Figure 2. North America Pharmaceutical Excipients Market Overview
  • Figure 3. Organic Chemicals Segment Held Largest Share of Product in Pharmaceutical Excipients Market
  • Figure 4. Oral Formulations Segment Held Largest Share of Type of Formulation in Pharmaceutical Excipients Market
  • Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Pharmaceutical Excipients Market - North America PEST Analysis
  • Figure 7. Pharmaceutical Excipients Market Impact Analysis of Driver and Restraints
  • Figure 8. North America Pharmaceutical Excipients Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 9. Pharmaceutical Excipients Market Share, by Product, 2019 and 2027 (%)
  • Figure 10. Organic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 11. Inorganic Chemicals: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 12. Other Products: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 13. Pharmaceutical Excipients Market Share, by Functionality, 2019 and 2027 (%)
  • Figure 14. Fillers and Diluents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 15. Suspending and Viscosity Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 16. Coating Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 17. Binders: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 18. Preservatives: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 19. Emulsifying Agents: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 20. Other Functionalities: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 21. Pharmaceutical Excipients Market Share, by Type of Formulation, 2019 and 2027 (%)
  • Figure 22. Oral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 23. Topical Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 24. Parenteral Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 25. Other Formulations: Pharmaceutical Excipients Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 26. North America: Pharmaceutical Excipients Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 27. North America: Pharmaceutical Excipients Market, by Country, 2019 & 2027 (%)
  • Figure 28. US: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Canada: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Mexico: Pharmaceutical Excipients Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 31. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 32. Growth Strategies Done by the Companies in the Market, (%)